| abstract |
Therapeutic agents for the treatment of peptic ulcer disease, containing as active ingredient, at least one compound of the general formula In n wherein one of R¹ and R³ isn n (wherein m is 1-5 R⁴ represents a (C₁-C₄)alkyl group); the other one of R¹ and R³ is hydrogen, (C₃-C₆)alkenyl or (C₁-C₈)alkyl which can be substituted with up to 2 hydroxyl groups or a (C₁-C₄)alkoxy group; and R² is (C₁-C₄)alkyl. |